In agreement with results observed using PKCε RNAi, pharmacological inhibition of PKCε significantly reduced the migratory ability of NSCLC cells in response to FBS (Fig. 5A and Fig. S7) without affecting cell viability (Fig. S5). Here, PRKCE is linked to non-small cell lung carcinoma.